Owens & Minor (NYSE:OMI)‘s stock had its “neutral” rating restated by investment analysts at Bank of America in a report issued on Wednesday, April 10th, Stock Target Advisor reports. They presently have a $4.50 target price on the stock, down from their prior target price of $7.00. Bank of America‘s price objective would indicate a potential upside of 21.62% from the company’s current price.
OMI has been the topic of a number of other research reports. ValuEngine upgraded shares of Owens & Minor from a “sell” rating to a “hold” rating in a research report on Saturday, February 2nd. UBS Group began coverage on shares of Owens & Minor in a research report on Thursday, January 17th. They set a “neutral” rating and a $8.00 price target on the stock. Zacks Investment Research lowered shares of Owens & Minor from a “hold” rating to a “sell” rating in a research report on Tuesday, January 8th. Barclays reiterated a “sell” rating and set a $6.00 price target on shares of Owens & Minor in a research report on Sunday, January 6th. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $7.00 price target on shares of Owens & Minor in a research report on Thursday, February 21st. Two equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $6.70.
Shares of OMI stock traded down $0.09 on Wednesday, reaching $3.70. The stock had a trading volume of 4,725 shares, compared to its average volume of 1,643,947. The stock has a market cap of $238.85 million, a price-to-earnings ratio of 3.23, a PEG ratio of 1.71 and a beta of 1.66. The company has a debt-to-equity ratio of 3.18, a quick ratio of 0.85 and a current ratio of 1.72. Owens & Minor has a 12 month low of $3.64 and a 12 month high of $19.16.
Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Tuesday, February 19th. The company reported $0.09 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.14 by ($0.05). The company had revenue of $2.54 billion during the quarter, compared to the consensus estimate of $2.51 billion. Owens & Minor had a negative net margin of 4.44% and a positive return on equity of 8.99%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.38 earnings per share. Sell-side analysts predict that Owens & Minor will post 0.64 EPS for the current fiscal year.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. FMR LLC grew its holdings in shares of Owens & Minor by 159,300.0% during the fourth quarter. FMR LLC now owns 4,782 shares of the company’s stock valued at $30,000 after buying an additional 4,779 shares during the last quarter. First Allied Advisory Services Inc. bought a new stake in Owens & Minor during the 4th quarter worth approximately $71,000. Magnus Financial Group LLC bought a new stake in Owens & Minor during the 4th quarter worth approximately $80,000. Campbell & CO Investment Adviser LLC bought a new stake in Owens & Minor during the 4th quarter worth approximately $85,000. Finally, Menta Capital LLC purchased a new position in Owens & Minor in the 4th quarter worth approximately $85,000. 95.28% of the stock is owned by institutional investors and hedge funds.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
See Also: Consumer behavior in bull markets
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.